Low Cobalamin Levels as Predictors of Cobalamin Deficiency: Importance of Comorbidities Associated with Increased Oxidative Stress

American Journal of Medicine

Volumn 129, Issue 1, 2016, Pages 115.e9-115.e16

  Solomon, Lawrence R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cobalamin; Homocysteine; Methylmalonic acid; Oxidative stress; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; OXIDIZING AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMORBIDITY; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC PARAMETERS; METABOLITE; METHYLMALONIC ACIDEMIA; MIDDLE AGED; OXIDATIVE STRESS; PRIORITY JOURNAL; REFERENCE VALUE; RISK FACTOR; SERUM; BLOOD; RETROSPECTIVE STUDY; VERY ELDERLY; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; COMORBIDITY; FEMALE; HOMOCYSTEINE; HUMANS; MALE; METHYLMALONIC ACID; MIDDLE AGED; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 84944111802     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.07.017     Document Type: Article

References (34)

1. 1 Stabler, S.P., Vitamin B12 deficiency. N Engl J Med 368 (2013), 149–160.
2. 2 Aparicio-Ugarriza, R., Palacios, G., Gonzalez-Cross, M., A review of the cut-off points for the diagnosis of vitamin B12 deficiency in the general population. Clin Chem Lab Med 53:8 (2015), 1149–1159.
3. 3 Bailey, R.L., Carmel, R., Green, R., et al. Monitoring of vitamin B12 nutritional status in the United States by using plasma MMA and serum vitamin B12. Am J Clin Nutr 94 (2011), 552–561.
4. 4 Solomon, L.R., Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev 21 (2007), 113–130.
5. 5 Holleland, G., Schneede, J., Ueland, P.M., Lund, P.K., Refsum, H., Sandberg, S., Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem 45 (1999), 189–198.
6. 6 Fayet-Moore, F., Petocz, P., Samman, S., Micronutrient status in female university students: iron, zinc, copper, selenium, vitamin B12 and folate. Nutrients 6 (2014), 5103–5116.
7. 7 Solomon, L.R., Functional cobalamin (vitamin B12) deficiency: role of advanced age and disorders associated with increased oxidative stress. Eur J Clin Nutr 69 (2015), 687–692.
8. 8 Vogiatzoglu, A., Oulhaj, A., Smith, D.A., et al. Determinants of plasma methylmalonic acid in a large population. Implications for the assessment of vitamin B12 status. Clin Chem 55 (2009), 2198–2206.
9. 9 Smith, A.D., Refsum, H., Do we need to reconsider the desirable blood level of vitamin B12?. J Intern Med 271 (2011), 179–182.
10. 10 Lindenbaum, J., Savage, D.G., Stabler, S.P., Allen, R.N., Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid and total homocysteine concentrations. Am J Hematol 34 (1990), 99–107.
11. 11 Magnus, E.M., Cobalamin and unsaturated transcobalamin values in pernicious anaemia: relation to treatment. Scand J Haematol 36 (1986), 457–465.
12. 12 Selhub, J., Jacques, P.F., Dallal, G., Choumenkovitch, S., Rogers, G., The use of blood concentrations of vitamins and theirs respective functional indicators to define folate and vitamin B12 status. Food Nutr Bull 29:suppl (2008), 567–573.
13. 13 Solomon, L.R., Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid and homocysteine testing. Blood 105 (2005), 978–985.
14. 14 Solomon, L.R., Diabetes mellitus as a cause of clinically significant functional cobalamin deficiency. Diabetes Care 34 (2011), 1077–1080.
15. 15 Dalle-Donne, I., Rossi, R., Colombo, R., Guestarini, D., Milzani, A., Biomarkers of oxidative damage in human disease. Clin Chem 52 (2006), 601–623.
16. 16 Pfeiffer, C.M., Caudill, S.P., Gunter, E.W., Osterloh, J., Sampson, E.J., Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2003. Am J Clin Nutr 82 (2005), 442–450.
17. 17 Sobczynska-Malefora, A., Gorska, R., Pelisser, M., Ruwona, P., Witchlow, B., Harrington, D.J., An audit of holotranscobalamin (“Active” B12) and methylmalonic acid assays for the assessment of vitamin B12 status: application in a mixed patient population. Clin Biochem 47 (2014), 82–86.
18. 18 Remacha, A.F., Sarda, M.P., Canals, C., et al. Role of serum holotranscobalamin (holoTC) in the diagnosis of patients with low serum cobalamin. Comparison with methylmalonic acid and homocysteine. Ann Hematol 93 (2014), 565–569.
19. 19 Hansen, J.M., Go, Y.-M., Jones, D.P., Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol 46 (2006), 215–234.
20. 20 Hvas, A.-M., Ellegard, J., Nexo, E., Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med 161 (2001), 1534–1541.
21. 21 Schilling, R.F., Is nitrous oxide a dangerous anesthetic for vitamin B12-deficient subjects?. JAMA 255 (1986), 1605–1606.
22. 22 Flippo, T.S., Holder, W.D., Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. Arch Surg 128 (1993), 1391–1395.
23. 23 Kinsella, L.J., Green, R., ‘Anesthesia paresthetica’: nitrous oxide induced cobalamin deficiency. Neurology 45 (1995), 1608–1610.
24. 24 Rosener, M., Dichgans, J., Severe combined degeneration of the spinal cord after nitrous oxide anaesthesia in a vegetarian. J Neurol Neurosurg Psychiatry, 60(3), 1996, 354.
25. 25 Sesso, R.M., Iunes, Y., Melo, A.C.P., Myeloneuropathy following nitrous oxide anaesthesia in a patient with macrocytic anaemia. Neuroradiology 41:8 (1999), 588–590.
26. 26 Ilniczky, S., Jelencsik, I., Kenez, J., Szirmai, I., MR findings in subacute degeneration of the spinal cord caused by nitrous oxide anaesthesia – two cases. Eur J Neurol 9 (2002), 101–104.
27. 27 Renard, D., Dutray, A., Remy, A., Castelnovo, G., Labauge, P., Subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia. Neurol Sci 30 (2009), 75–76.
28. 2O) abuse. J Emerg Med 41 (2011), 378–380.
29. 29 Solomon, L.R., Vitamin B12-responsive neuropathies: a case series. Nutr Neurosci, 2015 Feb 24 [Epub ahead of print].
30. 30 Celik, T., Kardesoglu, E., Iyisoy, A., Ozcan, O., Kilic, S., Yaman, H., Urinary methylmalonic acid in patients with acute myocardial infarction. Med Princ Pract 18:3 (2009), 217–222.
31. 31 Solomon, L.R., Oral pharmacologic doses of cobalamin may not be as effective as parenteral cobalamin therapy in reversing hyperhomocysteinemia and methylmalonic acidemia in apparently normal subjects. Clin Lab Haematol 28 (2006), 275–278.
32. 32 Xu, G., Lv, Z.W., Feng, Y., Tang, W.Z., Xu, G.X., A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia. Pain Med 14 (2013), 884–894.
33. 33 Kuwabara, S., Nakazawa, R., Azuma, N., et al. Intravenous methylcobalamin treatment of uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 38:6 (1999), 472–475.
34. 34 Ozcan, O., Ipcioglu, M., Gultepe, M., Basoglu, C., Altered red cell membrane compositions related to functional vitamin B12 deficiency manifested by elevated urine methylmalonic acid concentrations in patients with schizophrenia. Ann Clin Biochem 46 (2008), 44–49.